Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Revealing the potential of solute carrier family 31 (copper transporters), member 1: Insights into its role in bladder cancer progression and therapeutic implications.

International journal of immunopathology and pharmacology - 1 Jan 2000

Lin Yun-Zhi, Liu Wei-Hui, Wu Yu-Peng, Cai Hai, Zheng Qing-Shui, Wei Yong, Xu Ning, Xue Xue-Yi

Abstract excerpt

Introduction: Bladder cancer represents a significant public health concern with diverse genetic alterations influencing disease onset, progression, and therapy response. In this study, we explore the multifaceted role of Solute Carrier Family 31 Member 1 (SLC31A1) in bladder cancer, a pivotal gene involved in copper homeostasis. Methods: Our research involved analyzing the SLC31A1 gene expression via RT-qPCR,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Methylation

Share to Gene Expression Regulation, Neoplastic

Share to Prognosis

Share to Promoter Regions, Genetic

Share to Up-Regulation

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 38712735
DOI: 10.1177/03946320241240706
PMCID: PMC11080779

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Revealing the potential of solute carrier family 31 (copper transporters), member 1: Insights into its role in bladder cancer progression and therapeutic implications.PMID 38712735Read ↗

SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-CancerSemantic proximity Read ↗

Cuproptosis-related gene SLC31A1: prognosis values and potential biological functions in cancerSemantic proximity Read ↗

Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor typesSemantic proximity Read ↗

Systematic Pan-Cancer Analysis Identifies SLC31A1 as a Biomarker in Multiple Tumor TypesSemantic proximity Read ↗

A ceRNA network-mediated over-expression of cuproptosis-related gene SLC31A1 correlates with poor prognosis and positive immune infiltration in breast cancerSemantic proximity Read ↗

Comprehensive Pan-cancer Analysis of Cuproptosis-related Gene SLC31A1 as a Potential Biomarker for Cancer Survival and ImmunotherapySemantic proximity Read ↗

Tumor microenvironment exploration and therapeutic target identification in bladder cancer based on Cuproptosis signature and chemotherapy-resistant model: results from bioinformatics and experimental validationSemantic proximity Read ↗

Hypermethylation Loci of ZNF671, IRF8, and OTX1 as Potential Urine-Based Predictive Biomarkers for Bladder CancerSemantic proximity Read ↗

Identification and experimental validation of biomarkers associated with amino acid metabolism and ferroptosis in bladder cancerSemantic proximity Read ↗

Methylcap-Seq Reveals Novel DNA Methylation Markers for the Diagnosis and Recurrence Prediction of Bladder Cancer in a Chinese PopulationSemantic proximity Read ↗

Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer.Semantic proximity Read ↗

CYP19A1 polymorphisms and bladder cancer risk in the Chinese Han population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.